Biomaterials Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)
Market Report I 2026-05-20 I 350 Pages I EMR Inc.
The biomaterials market was valued at USD 167.39 Billion in 2025 . It is poised to grow at a CAGR of 14.20% during the forecast period of 2026-2035, and reach USD 631.53 Billion by 2035 . The market growth is driven by the growing demand for implants and prosthetics, advancements in regenerative medicine, and an increasing aging population, fueling market growth, alongside innovations in biocompatible materials and rising healthcare expenditure worldwide.
Key Market Trends and Insights
- Based on region, North America market held the largest share of around 38% of the global market in the historical period.
- By product, the metallic segment held the largest market share of above 40% during the historical period.
- Based on application, orthopedic segment accounted for the largest revenue share of nearly 24% during the historical period.
Market Size and Forecast
- Market Size (2025): USD 167.39 Billion
- Projected Market Size (2035): USD 631.53 Billion
- CAGR (2026-2035): 14.20%
Biomaterials Market Overview
The biomaterials market is expanding steadily, driven by increasing demand for advanced polymer biomaterial applications in medical devices and implants. Growing use of ceramic biomaterials and collagen-based materials supports orthopedic and cardiovascular treatments. Innovations in degradable biomaterials and tissue engineering scaffolds are enhancing clinical outcomes, while advancements in surface modification are improving implant performance and long-term therapeutic efficiency. The market reached a value of approximately USD 167.39 Billion in 2025 .
Biomaterials Market Growth Drivers
Growing Focus on Smart Drug Delivery Systems to Propel the Market Demand
Increasing focus on programmable biomaterials is advancing next-generation therapeutics, particularly enhancing hydrogel-based delivery systems. For instance, in January 2026, researchers developed DNA-based hydrogels with tunable degradation and controlled antibody release capabilities. These smart biomaterials allow precise modulation of drug delivery and responsiveness to biological triggers, supporting personalized medicine approaches and enhancing the role of biomaterials in advanced therapeutic systems.
Biomaterials Market Trends
Key trends shaping the market include smart biomaterials, injectable hydrogels, microfluidic fabrication, regenerative medicine demand, and growing interdisciplinary research collaborations globally.
Technological Advancements in Biomaterials Engineering to Support the Market Expansion
Technological convergence between microfluidics and biomaterials engineering is advancing therapeutic innovation, particularly improving biocompatibility across next-generation solutions. For instance, in February 2026, a study titled "Microfluidic Fabrication of DNA Hydrogels with Controlled Swelling and Dissolution Properties," published on arXiv, introduced a scalable fabrication approach enabling precise control over hydrogel properties, supporting applications in biosensing, drug delivery, and tissue engineering. These advancements support high-precision applications such as biosensing, targeted drug delivery, and tissue engineering, strengthening the role of engineered biomaterials in translational research.
Biomaterials Market Segmentation
Market Breakup by Product Type
- Metallic
??- Stainless Steel
??- Gold
??- Cobalt-Chrome
??- Others
- Natural
??- Hyaluronic Acid
??- Cellulose
??- Gelatin
??- Others
- Ceramics
??- Calcium Phosphate
??- Aluminum Oxide
??- Glass
??- Others
- Polymers
??- Polyethylene
??- Polyester
??- Nylon
??- Others
Market Breakup by Application
- Orthopedic
??- Orthobiologics
??- Viscosupplementation
??- Spine Biomaterials
??- Others
- Cardiovascular
??- Sensors
??- Stents
??- Pacemakers
??- Vascular Grafts
??- Others
- Ophthalmology
??- Synthetic Corneas
??- Intraocular Lens
??- Contact Lens
??- Ocular Tissue Replacement
??- Others
- Dental
??- Tissue Regeneration Materials
??- Dental Implants
??- Grafts and Substitutes
??- Others
- Plastic Surgery
??- Soft Tissue Fillers
??- Peripheral Nerve Repair
??- Acellular Dermal Matrices
??- Others
- Wound Healing
??- Fracture Healing Devices
??- Adhesion Barrier
??- Internal Tissue Sealant
??- Others
- Tissue Engineering
- Neurological/Central Nervous System
??- Neural Stem Cell Encapsulation
??- Shunting Systems
??- Hydrogel Scaffold for CNS Repair
??- Cortical Neural Prosthetics
??- Others
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Biomaterials Market Share
Metallic Segment Expected to Lead the Market Segment by Product Type
The market share was led by the metallic segment, which held the largest share of above 40% in the historical period. This dominance is attributed to its extensive use in orthopedic and titanium implant applications, along with dental and cardiovascular devices. Strong durability and cost-effectiveness further supported adoption. Increasing demand for advanced medical implants and continuous material innovation also contributed to sustained global growth.
Biomaterials Market Analysis by Region
North America held the largest share of around 38% of the global market in the historical period. This leadership is driven by advanced healthcare infrastructure, high adoption of innovative biomaterials, and growing demand for tissue engineering scaffold solutions. Additionally, rising chronic disease prevalence, increasing surgical procedures, and significant R&D investments further strengthened the region's overall market dominance.
Leading Players in the Biomaterials Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Noble Biomaterials Inc.
Noble Biomaterials Inc. is a U.S.-based advanced materials company headquartered in Scranton, Pennsylvania, and founded in 1997. It specializes in antimicrobial and conductive biomaterials used in medical textiles, wound care, and infection control. Its key portfolio includes silver-based technologies like Ionic+ and Circuitex, widely used in healthcare, military, and performance apparel applications for enhanced protection and biocompatibility.
Zimmer Biomet
Zimmer Biomet is a leading U.S. medical device company headquartered in Warsaw, Indiana, established in 1927. It offers a strong biomaterials portfolio focused on orthopedic implants, joint reconstruction, spine systems, and bone graft substitutes. The company is a global leader in regenerative orthopedic solutions, supporting knee, hip, and dental applications with advanced implantable biomaterials and robotic-assisted surgical technologies.
Corbion NV
Corbion NV is a Netherlands-based company headquartered in Amsterdam and founded in 1919. It focuses on sustainable biomaterials including lactic acid, polylactic acid (PLA), and biodegradable polymers. Its portfolio supports medical implants, tissue regeneration, drug delivery systems, and orthopedic applications, making it a key player in bio-based and eco-friendly medical material innovations.
Koninklijke DSM N.V.
Koninklijke DSM N.V. is a Dutch multinational headquartered in Heerlen, Netherlands, founded in 1902. It provides advanced biomaterials for regenerative medicine, biocompatible polymers, and medical-grade materials. Its portfolio supports tissue engineering, implantable devices, and drug delivery systems, with a strong emphasis on sustainable life sciences solutions and innovative biomedical material development globally.
Other key players in the market are BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Evonik Industries AG, Victrex plc, Coorstek Inc., and CeramTec GmbH.
Key Questions Answered in the Biomaterials Market
- What was the biomaterials market value in 2025?
- What is the biomaterials market forecast outlook for 2026-2035?
- What major factors aid the demand for biomaterials market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major biomaterials market trends?
- Which product type is expected to dominate the market segment?
- Which application is expected to dominate the market segment?
- Who are the key players in the biomaterials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biomaterials Market Overview
3.1 Global Biomaterials Market Historical Value (2019-2025)
3.2 Global Biomaterials Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Biomaterials Market Landscape*
5.1 Global Biomaterials Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Biomaterials Market: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 Global Biomaterials Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Biomaterials Market Segmentation (219-2035)
7.1 Global Biomaterials Market (2019-2035) by Product Type
7.1.1 Market Overview
7.1.2 Metallic
7.1.2.1 Stainless Steel
7.1.2.2 Gold
7.1.2.3 Cobalt-Chrome
7.1.2.4 Others
7.1.3 Natural
7.1.3.1 Hyaluronic Acid
7.1.3.2 Cellulose
7.1.3.3 Gelatin
7.1.3.4 Others
7.1.4 Ceramics
7.1.4.1 Calcium Phosphate
7.1.4.2 Aluminum Oxide
7.1.4.3 Glass
7.1.4.4 Others
7.1.5 Polymers
7.1.5.1 Polyethylene
7.1.5.2 Polyester
7.1.5.3 Nylon
7.1.5.4 Others
7.2 Global Biomaterials Market (2019-2035) by Application
7.2.1 Market Overview
7.2.2 Orthopedic
7.2.2.1 Orthobiologics
7.2.2.2 Viscosupplementation
7.2.2.3 Spine Biomaterials
7.2.2.4 Others
7.2.3 Cardiovascular
7.2.3.1 Sensors
7.2.3.2 Stents
7.2.3.3 Pacemakers
7.2.3.4 Vascular Grafts
7.2.3.5 Others
7.2.4 Ophthalmology
7.2.4.1 Synthetic Corneas
7.2.4.2 Intraocular Lens
7.2.4.3 Contact Lens
7.2.4.4 Ocular Tissue Replacement
7.2.4.5 Others
7.2.5 Dental
7.2.5.1 Tissue Regeneration Materials
7.2.5.2 Dental Implants
7.2.5.3 Grafts and Substitutes
7.2.5.4 Others
7.2.6 Plastic Surgery
7.2.6.1 Soft Tissue Fillers
7.2.6.2 Peripheral Nerve Repair
7.2.6.3 Acellular Dermal Matrices
7.2.6.4 Others
7.2.7 Wound Healing
7.2.7.1 Fracture Healing Devices
7.2.7.2 Adhesion Barrier
7.2.7.3 Internal Tissue Sealant
7.2.7.4 Others
7.2.8 Tissue Engineering
7.2.9 Neurological/Central Nervous System
7.2.9.1 Neural Stem Cell Encapsulation
7.2.9.2 Shunting Systems
7.2.9.3 Hydrogel Scaffold for CNS Repair
7.2.9.4 Cortical Neural Prosthetics
7.2.9.5 Others
7.2.10 Others
7.3 Global Biomaterials Market (2019-2035) by Region
7.3.1 Market Overview
7.3.2 North America
7.3.3 Europe
7.3.4 Asia Pacific
7.3.5 Latin America
7.3.6 Middle East and Africa
8 North America Biomaterials Market (219-2035)
8.1 North America Biomaterials Market (2019-2035) by Product Type
8.1.1 Market Overview
8.1.2 Metallic
8.1.2.1 Stainless Steel
8.1.2.2 Gold
8.1.2.3 Cobalt-Chrome
8.1.2.4 Others
8.1.3 Natural
8.1.3.1 Hyaluronic Acid
8.1.3.2 Cellulose
8.1.3.3 Gelatin
8.1.3.4 Others
8.1.4 Ceramics
8.1.4.1 Calcium Phosphate
8.1.4.2 Aluminum Oxide
8.1.4.3 Glass
8.1.4.4 Others
8.1.5 Polymers
8.1.5.1 Polyethylene
8.1.5.2 Polyester
8.1.5.3 Nylon
8.1.5.4 Others
8.2 North America Biomaterials Market (2019-2035) by Application
8.2.1 Market Overview
8.2.2 Orthopedic
8.2.2.1 Orthobiologics
8.2.2.2 Viscosupplementation
8.2.2.3 Spine Biomaterials
8.2.2.4 Others
8.2.3 Cardiovascular
8.2.3.1 Sensors
8.2.3.2 Stents
8.2.3.3 Pacemakers
8.2.3.4 Vascular Grafts
8.2.3.5 Others
8.2.4 Ophthalmology
8.2.4.1 Synthetic Corneas
8.2.4.2 Intraocular Lens
8.2.4.3 Contact Lens
8.2.4.4 Ocular Tissue Replacement
8.2.4.5 Others
8.2.5 Dental
8.2.5.1 Tissue Regeneration Materials
8.2.5.2 Dental Implants
8.2.5.3 Grafts and Substitutes
8.2.5.4 Others
8.2.6 Plastic Surgery
8.2.6.1 Soft Tissue Fillers
8.2.6.2 Peripheral Nerve Repair
8.2.6.3 Acellular Dermal Matrices
8.2.6.4 Others
8.2.7 Wound Healing
8.2.7.1 Fracture Healing Devices
8.2.7.2 Adhesion Barrier
8.2.7.3 Internal Tissue Sealant
8.2.7.4 Others
8.2.8 Tissue Engineering
8.2.9 Neurological/Central Nervous System
8.2.9.1 Neural Stem Cell Encapsulation
8.2.9.2 Shunting Systems
8.2.9.3 Hydrogel Scaffold for CNS Repair
8.2.9.4 Cortical Neural Prosthetics
8.2.9.5 Others
8.2.10 Others
8.3 North America Biomaterials Market (2019-2035) by Country
8.3.1 United States of America
8.3.1.1 United States of America Biomaterials Market (2019-2035) by Product Type
8.3.2 Canada
8.3.2.1 Canada Biomaterials Market (2019-2035) by Product Type
9 Europe Biomaterials Market (219-2035)
9.1 Europe Biomaterials Market (2019-2035) by Product Type
9.1.1 Market Overview
9.1.2 Metallic
9.1.2.1 Stainless Steel
9.1.2.2 Gold
9.1.2.3 Cobalt-Chrome
9.1.2.4 Others
9.1.3 Natural
9.1.3.1 Hyaluronic Acid
9.1.3.2 Cellulose
9.1.3.3 Gelatin
9.1.3.4 Others
9.1.4 Ceramics
9.1.4.1 Calcium Phosphate
9.1.4.2 Aluminum Oxide
9.1.4.3 Glass
9.1.4.4 Others
9.1.5 Polymers
9.1.5.1 Polyethylene
9.1.5.2 Polyester
9.1.5.3 Nylon
9.1.5.4 Others
9.2 Europe Biomaterials Market (2019-2035) by Application
9.2.1 Market Overview
9.2.2 Orthopedic
9.2.2.1 Orthobiologics
9.2.2.2 Viscosupplementation
9.2.2.3 Spine Biomaterials
9.2.2.4 Others
9.2.3 Cardiovascular
9.2.3.1 Sensors
9.2.3.2 Stents
9.2.3.3 Pacemakers
9.2.3.4 Vascular Grafts
9.2.3.5 Others
9.2.4 Ophthalmology
9.2.4.1 Synthetic Corneas
9.2.4.2 Intraocular Lens
9.2.4.3 Contact Lens
9.2.4.4 Ocular Tissue Replacement
9.2.4.5 Others
9.2.5 Dental
9.2.5.1 Tissue Regeneration Materials
9.2.5.2 Dental Implants
9.2.5.3 Grafts and Substitutes
9.2.5.4 Others
9.2.6 Plastic Surgery
9.2.6.1 Soft Tissue Fillers
9.2.6.2 Peripheral Nerve Repair
9.2.6.3 Acellular Dermal Matrices
9.2.6.4 Others
9.2.7 Wound Healing
9.2.7.1 Fracture Healing Devices
9.2.7.2 Adhesion Barrier
9.2.7.3 Internal Tissue Sealant
9.2.7.4 Others
9.2.8 Tissue Engineering
9.2.9 Neurological/Central Nervous System
9.2.9.1 Neural Stem Cell Encapsulation
9.2.9.2 Shunting Systems
9.2.9.3 Hydrogel Scaffold for CNS Repair
9.2.9.4 Cortical Neural Prosthetics
9.2.9.5 Others
9.2.10 Others
9.3 Europe Biomaterials Market (2019-2035) by Country
9.3.1 United Kingdom
9.3.1.1 United Kingdom Biomaterials Market (2019-2035) by Product Type
9.3.2 Germany
9.3.2.1 Germany Biomaterials Market (2019-2035) by Product Type
9.3.3 France
9.3.3.1 France Biomaterials Market (2019-2035) by Product Type
9.3.4 Italy
9.3.4.1 Italy Biomaterials Market (2019-2035) by Product Type
9.3.5 Others
10 Asia Pacific Biomaterials Market (219-2035)
10.1 Asia Pacific Biomaterials Market (2019-2035) by Product Type
10.1.1 Market Overview
10.1.2 Metallic
10.1.2.1 Stainless Steel
10.1.2.2 Gold
10.1.2.3 Cobalt-Chrome
10.1.2.4 Others
10.1.3 Natural
10.1.3.1 Hyaluronic Acid
10.1.3.2 Cellulose
10.1.3.3 Gelatin
10.1.3.4 Others
10.1.4 Ceramics
10.1.4.1 Calcium Phosphate
10.1.4.2 Aluminum Oxide
10.1.4.3 Glass
10.1.4.4 Others
10.1.5 Polymers
10.1.5.1 Polyethylene
10.1.5.2 Polyester
10.1.5.3 Nylon
10.1.5.4 Others
10.2 Asia Pacific Biomaterials Market (2019-2035) by Application
10.2.1 Market Overview
10.2.2 Orthopedic
10.2.2.1 Orthobiologics
10.2.2.2 Viscosupplementation
10.2.2.3 Spine Biomaterials
10.2.2.4 Others
10.2.3 Cardiovascular
10.2.3.1 Sensors
10.2.3.2 Stents
10.2.3.3 Pacemakers
10.2.3.4 Vascular Grafts
10.2.3.5 Others
10.2.4 Ophthalmology
10.2.4.1 Synthetic Corneas
10.2.4.2 Intraocular Lens
10.2.4.3 Contact Lens
10.2.4.4 Ocular Tissue Replacement
10.2.4.5 Others
10.2.5 Dental
10.2.5.1 Tissue Regeneration Materials
10.2.5.2 Dental Implants
10.2.5.3 Grafts and Substitutes
10.2.5.4 Others
10.2.6 Plastic Surgery
10.2.6.1 Soft Tissue Fillers
10.2.6.2 Peripheral Nerve Repair
10.2.6.3 Acellular Dermal Matrices
10.2.6.4 Others
10.2.7 Wound Healing
10.2.7.1 Fracture Healing Devices
10.2.7.2 Adhesion Barrier
10.2.7.3 Internal Tissue Sealant
10.2.7.4 Others
10.2.8 Tissue Engineering
10.2.9 Neurological/Central Nervous System
10.2.9.1 Neural Stem Cell Encapsulation
10.2.9.2 Shunting Systems
10.2.9.3 Hydrogel Scaffold for CNS Repair
10.2.9.4 Cortical Neural Prosthetics
10.2.9.5 Others
10.2.10 Others
10.3 Asia Pacific Biomaterials Market (2019-2035) by Country
10.3.1 China
10.3.1.1 China Biomaterials Market (2019-2035) by Product Type
10.3.2 Japan
10.3.2.1 Japan Biomaterials Market (2019-2035) by Product Type
10.3.3 India
10.3.3.1 India Biomaterials Market (2019-2035) by Product Type
10.3.4 ASEAN
10.3.4.1 ASEAN Biomaterials Market (2019-2035) by Product Type
10.3.5 Australia
10.3.5.1 Australia Biomaterials Market (2019-2035) by Product Type
10.3.6 Others
11 Latin America Biomaterials Market (219-2035)
11.1 Latin America Biomaterials Market (2019-2035) by Product Type
11.1.1 Market Overview
11.1.2 Metallic
11.1.2.1 Stainless Steel
11.1.2.2 Gold
11.1.2.3 Cobalt-Chrome
11.1.2.4 Others
11.1.3 Natural
11.1.3.1 Hyaluronic Acid
11.1.3.2 Cellulose
11.1.3.3 Gelatin
11.1.3.4 Others
11.1.4 Ceramics
11.1.4.1 Calcium Phosphate
11.1.4.2 Aluminum Oxide
11.1.4.3 Glass
11.1.4.4 Others
11.1.5 Polymers
11.1.5.1 Polyethylene
11.1.5.2 Polyester
11.1.5.3 Nylon
11.1.5.4 Others
11.2 Latin America Biomaterials Market (2019-2035) by Application
11.2.1 Market Overview
11.2.2 Orthopedic
11.2.2.1 Orthobiologics
11.2.2.2 Viscosupplementation
11.2.2.3 Spine Biomaterials
11.2.2.4 Others
11.2.3 Cardiovascular
11.2.3.1 Sensors
11.2.3.2 Stents
11.2.3.3 Pacemakers
11.2.3.4 Vascular Grafts
11.2.3.5 Others
11.2.4 Ophthalmology
11.2.4.1 Synthetic Corneas
11.2.4.2 Intraocular Lens
11.2.4.3 Contact Lens
11.2.4.4 Ocular Tissue Replacement
11.2.4.5 Others
11.2.5 Dental
11.2.5.1 Tissue Regeneration Materials
11.2.5.2 Dental Implants
11.2.5.3 Grafts and Substitutes
11.2.5.4 Others
11.2.6 Plastic Surgery
11.2.6.1 Soft Tissue Fillers
11.2.6.2 Peripheral Nerve Repair
11.2.6.3 Acellular Dermal Matrices
11.2.6.4 Others
11.2.7 Wound Healing
11.2.7.1 Fracture Healing Devices
11.2.7.2 Adhesion Barrier
11.2.7.3 Internal Tissue Sealant
11.2.7.4 Others
11.2.8 Tissue Engineering
11.2.9 Neurological/Central Nervous System
11.2.9.1 Neural Stem Cell Encapsulation
11.2.9.2 Shunting Systems
11.2.9.3 Hydrogel Scaffold for CNS Repair
11.2.9.4 Cortical Neural Prosthetics
11.2.9.5 Others
11.2.10 Others
11.3 Latin America Biomaterials Market (2019-2035) by Country
11.3.1 Brazil
11.3.1.1 Brazil Biomaterials Market (2019-2035) by Product Type
11.3.2 Argentina
11.3.2.1 Argentina Biomaterials Market (2019-2035) by Product Type
11.3.3 Mexico
11.3.3.1 Mexico Biomaterials Market (2019-2035) by Product Type
11.3.4 Others
12 Middle East and Africa Biomaterials Market (219-2035)
12.1 Middle East and Africa Biomaterials Market (2019-2035) by Product Type
12.1.1 Market Overview
12.1.2 Metallic
12.1.2.1 Stainless Steel
12.1.2.2 Gold
12.1.2.3 Cobalt-Chrome
12.1.2.4 Others
12.1.3 Natural
12.1.3.1 Hyaluronic Acid
12.1.3.2 Cellulose
12.1.3.3 Gelatin
12.1.3.4 Others
12.1.4 Ceramics
12.1.4.1 Calcium Phosphate
12.1.4.2 Aluminum Oxide
12.1.4.3 Glass
12.1.4.4 Others
12.1.5 Polymers
12.1.5.1 Polyethylene
12.1.5.2 Polyester
12.1.5.3 Nylon
12.1.5.4 Others
12.2 Middle East and Africa Biomaterials Market (2019-2035) by Application
12.2.1 Market Overview
12.2.2 Orthopedic
12.2.2.1 Orthobiologics
12.2.2.2 Viscosupplementation
12.2.2.3 Spine Biomaterials
12.2.2.4 Others
12.2.3 Cardiovascular
12.2.3.1 Sensors
12.2.3.2 Stents
12.2.3.3 Pacemakers
12.2.3.4 Vascular Grafts
12.2.3.5 Others
12.2.4 Ophthalmology
12.2.4.1 Synthetic Corneas
12.2.4.2 Intraocular Lens
12.2.4.3 Contact Lens
12.2.4.4 Ocular Tissue Replacement
12.2.4.5 Others
12.2.5 Dental
12.2.5.1 Tissue Regeneration Materials
12.2.5.2 Dental Implants
12.2.5.3 Grafts and Substitutes
12.2.5.4 Others
12.2.6 Plastic Surgery
12.2.6.1 Soft Tissue Fillers
12.2.6.2 Peripheral Nerve Repair
12.2.6.3 Acellular Dermal Matrices
12.2.6.4 Others
12.2.7 Wound Healing
12.2.7.1 Fracture Healing Devices
12.2.7.2 Adhesion Barrier
12.2.7.3 Internal Tissue Sealant
12.2.7.4 Others
12.2.8 Tissue Engineering
12.2.9 Neurological/Central Nervous System
12.2.9.1 Neural Stem Cell Encapsulation
12.2.9.2 Shunting Systems
12.2.9.3 Hydrogel Scaffold for CNS Repair
12.2.9.4 Cortical Neural Prosthetics
12.2.9.5 Others
12.2.10 Others
12.3 Middle East and Africa Biomaterials Market (2019-2035) by Country
12.3.1 Saudi Arabia
12.3.1.1 Saudi Arabia Biomaterials Market (2019-2035) by Product Type
12.3.2 United Arab Emirates
12.3.2.1 United Arab Emirates Biomaterials Market (2019-2035) by Product Type
12.3.3 Nigeria
12.3.3.1 Nigeria Biomaterials Market (2019-2035) by Product Type
12.3.4 South Africa
12.3.4.1 South Africa Biomaterials Market (2019-2035) by Product Type
12.3.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Initiatives
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Zimmer Biomet
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 Noble Biomaterials Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 BASF SE
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Covestro AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Celanese Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Carpenter Technology Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 Evonik Industries AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 Koninklijke DSM N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 Corbion NV
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
17.11 Victrex plc
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Development
17.11.5 Certifications
17.12 CeramTec GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Company News and Development
17.12.5 Certifications
17.13 Coorstek Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Company News and Development
17.13.5 Certifications
18 Global Biomaterials Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.